companydata.dkBOOST Pharma ApS: Financial statements 2020
CVR: 41120495
BOOST Pharma ApS (CVR 41120495) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -20,919 and a net result of DKK -63,347. Equity amounted to DKK -23,345.
- Gross Profit
- -20,919 kr.
- Profit/Loss
- -63,347 kr.
- Equity
- -23,345 kr.
- Total Assets
- 3,683,419 kr.
How creditworthy is BOOST Pharma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of January 20, 2020, Lilian Karin Florence Walter Jallow is registered as director of BOOST Pharma ApS.
As of January 20, 2020, Anna Cecilia Götherström is registered as director of BOOST Pharma ApS.
As of January 20, 2020, Lars Magnus Reinhold Westgren is registered as director of BOOST Pharma ApS.
BOOST Pharma ApS was founded on January 20, 2020.
About BOOST Pharma ApS
BOOST Pharma ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2020. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Hans Thalsgård Schambye. The company is owned by BOOST Pharma AB. In 2025, the company reported a gross profit of DKK -7,557,572 and a net result of DKK -9,243,488 compared with DKK -4,259,583 the year before. Equity amounted to DKK -11,850,535.